CN103275085B - Quinazoline and quinazolinone compound, its synthesis method and application - Google Patents
Quinazoline and quinazolinone compound, its synthesis method and application Download PDFInfo
- Publication number
- CN103275085B CN103275085B CN201310224222.7A CN201310224222A CN103275085B CN 103275085 B CN103275085 B CN 103275085B CN 201310224222 A CN201310224222 A CN 201310224222A CN 103275085 B CN103275085 B CN 103275085B
- Authority
- CN
- China
- Prior art keywords
- compound
- quinazolinones
- quinazo
- reaction
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 *C(Cc1cc(Cl)ccc1*)=O Chemical compound *C(Cc1cc(Cl)ccc1*)=O 0.000 description 7
- NDOPHXWIAZIXPR-UHFFFAOYSA-N O=Cc(cccc1)c1Br Chemical compound O=Cc(cccc1)c1Br NDOPHXWIAZIXPR-UHFFFAOYSA-N 0.000 description 1
Abstract
The invention relates to a quinazoline and quinazolinone compound, its synthesis method and application. According to the synthesis method, a copper compound is taken as a catalyst. The quinazoline and quinazolinone compound is prepared by one step reaction of dihydroquinolinone and amidine compound. The synthesis method has advantages of mild reaction condition, high product yield, simple post-processing. Furthermore, the quinazoline and quinazolinone compound is surprisingly found that it has an obvious fluorescent intensity alteration characteristic, which can be used in the application field of fluorescence sensing and has wide application prospect and research value.
Description
Technical field
The present invention relates to a kind of nitrogen heterocyclic ring compounds, particularly a kind of quinazo quinazolinones and preparation method and use thereof, belong to organic chemistry filed.
Background technology
Many rings nitrogen-containing heterocycle compound is present in occurring in nature widely, wherein some are used to drug research because having certain biological activity, such as find with quinazolinone to be that the polynuclear compound of skeleton is present in the core texture skeleton of the multiple natural product that can be used as medicine already, such as, be present in deoxidation Adhatoda vasica Nees ketone alkali (deoxyvasicinone), the peaceful alkali A of camel (Luotonin A), Circumdatins, Rutaecarpine (Rutaecarpine) and couroupitine A (Tryptanthrin) isoreactivity compound.Quinazolinones due to many rings has multi-medicament activity, receive showing great attention to and paying attention to of medicament research and development personnel as many pharmacologically actives such as antitumor, antibacterium, antimycotic, antidepressant, anti-inflammatory, rheumatism, hypertension, spasmolytic, anti-malarial, anti-infective and pain relieving, and develop multiple quianzolinones and chemical synthesis process thereof.
Li Shuyi (" study on the synthesis of Quinazol derivative ", Northwest University's Master's thesis, 2009) disclose a kind of methodology of organic synthesis preparing Quinazol derivative, described method utilizes Microwave-assisted synthesis, react with substituted benzoic acid and methane amide, and use Isosorbide-5-Nitrae-butynediol, L-glutaminate and isatoic anhydride to react, and obtain multiple Quinazol derivative.
CN1845908A discloses class 5-substituted quinazoline ketone and preparation method thereof, and described quinazolinone can be used as α-1A/B adrenergic receptor antagonist.
CN101415688A discloses a class Quinazol derivative, and it has B-RAF inhibit activities, can be used in the anticancer therapy of the mankind.
CN1628104A discloses a class Quinazol derivative, and it can be used as CB agonist.
CN1538966A discloses a class Quinazol derivative, and described derivative has M3 selectivity M-ChR antagonistic action and rhythmic bladder contraction frequency restraining effect, can be used to treatment frequent micturition or the urinary incontinence.
CN101429166A discloses a kind of Quinazol derivative and its production and use, it has the PDES inhibit activities stronger than Virga, and relative to being distributed in amphiblestroid PED6, there is higher selectivity, thus show better security and validity clinically.
CN1683844A discloses a kind of 4-Quinazol derivative and the application in antitumor drug thereof, and described derivative has anti-tumor activity.
CN1856485A discloses a kind of benzimidazolone and Quinazol derivative, and described compound can be used as the agonist of mankind ORL1 acceptor, thus can treat the disease relating to ORL1 acceptor.
CN1845924A discloses the quinazolinones that a kind of arylamines replaces, the disease that described compounds-treatable is relevant with making α-1A/B adrenoceptor activity.
CN1708306A discloses a kind of quinazolinones, and it can be used as calcium retarding agent, thus plays the effect of Calcilytic.
CN1980899A discloses a kind of Quinazol derivative, and described derivative can be used as PARP inhibitor, can be used to treat the multiple disease relating to PARP.
As mentioned above, although disclose the multiple method preparing quinazolinone in prior art, the compound simultaneously condensing skeleton containing quinazolinone and quinazoline rarely has report, more leisure opinion its preparation method route and method.
In addition, up to now, all research relating to quinazolinone all concentrates in its pharmaceutical activity performance, has carried out large quantifier elimination for cure mechanism, activity etc., but never relates to other purposes research except pharmaceutical activity.
Therefore, find the purposes that it is new, and under the prerequisite of this novelty teabag, seek this new compounds, and its brand-new preparation method is the Focal point and difficult point problem existed at present, is also the starting point that the present invention is accomplished and realizes.
Summary of the invention
In view of this, in order to seek new quinazo quinazolinones, its preparation method and new purposes thereof, present inventor has performed further investigation, after having paid a large amount of creative works, thus completes the present invention.
Specifically, technical scheme of the present invention and content relate to three aspects: quinazo quinazolinones, its preparation method and new purposes thereof.
First aspect, the present invention relates to a kind of quinazo quinazolinones, and its structural formula is as shown in the formula shown in (I).
Wherein:
R
1-R
4identical or different separately, and independently selected from H, C
1-C
6alkyl, halogen, C1-C6 alkoxyl group;
R is selected from C
1-C
6alkyl, C
1-C
6alkoxyl group, C
3-C
6cycloalkyl;
Condition is when R is methyl, R
1-R
4be asynchronously H.
In the present invention, unless otherwise prescribed, from start to finish, C
1-C
6the implication of alkyl refers to the straight or branched alkyl with 1-6 carbon atom, that includes C
1alkyl, C
2alkyl, C
3alkyl, C
4alkyl, C
5alkyl or C
6alkyl, such as can be methyl, ethyl, n-propyl, sec.-propyl, normal-butyl, sec-butyl, isobutyl-, the tertiary butyl, n-pentyl, isopentyl or n-hexyl etc. in non-limiting manner.
In the present invention, unless otherwise prescribed, from start to finish, C
1-C
6alkoxyl group refers to " C defined above
1-C
6alkyl " the group after being connected with O atom.
In the present invention, unless otherwise prescribed, from start to finish, C
3-C
6the implication of cycloalkyl refers to the cyclic alkyl with 3-6 carbon atom, that includes C
3cycloalkyl, C
4cycloalkyl, C
5cycloalkyl or C
6cycloalkyl, non-exclusively such as can be cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl.
In the present invention, unless otherwise prescribed, from start to finish, the implication of halogen refers to haloid element, non-exclusively such as can be F, Cl, Br or I.
As a kind of preferred implementation, R is C
2-C
6alkyl or C
3-C
6cycloalkyl, is preferably ethyl or cyclopropyl.
As a kind of preferred implementation, R
4for H.
Second aspect, the present invention relates to the synthetic method of the quinazo quinazolinones of formula (I).
Described method is included under copper source catalyzer and alkali exist, and makes formula (II) and (III) react and obtain formula (I) compound in organic solvent.
Wherein, R
1-R
4, R definition described above.
X is halogen, such as, can be F, Cl, Br or I.
In described synthetic method of the present invention, described copper source catalyzer is Inorganic Copper, organic copper or both mixtures.
Described Inorganic Copper is selected from copper halide or cuprous halide, such as can be CuI, CuBr, CuCl, CuCl in non-limiting manner
2, CuBr
2, CuI
2in any one or multiple, namely described copper source catalyzer can be in these concrete materials any one or multiple.
Described organic copper is selected from venus crystals [Cu (OAc)
2], acetylacetone copper [Cu (acac)
2], Cu (PPh
3)
2nO
3, ethyl acetoacetic acid copper (II), any one or multiple in hexafluoroacetylacetone copper, namely described copper source catalyzer can be in these concrete materials any one or multiple.
Described copper source catalyzer is preferably Cu (acac)
2, hexafluoroacetylacetone copper, Cu (PPh
3)
2nO
3, most preferably be Cu (acac)
2.
In described synthetic method of the present invention, described alkali such as can be any one or multiple in alkali-metal carbonate, phosphoric acid salt, oxyhydroxide, alkoxide.
Illustratively, described alkali such as can be any one or multiple in salt of wormwood, potassiumphosphate, Quilonum Retard, lithium hydroxide, cesium carbonate.
Described alkali is preferably potassiumphosphate, salt of wormwood, lithium hydroxide or cesium carbonate, most preferably is cesium carbonate.
In described synthetic method of the present invention, reaction solvent when formula (II) and (III) react is not particularly limited, can be in organic synthesis field any conventional organic solvent used, such as can be benzene in non-limiting manner, toluene, dimethylbenzene, chlorobenzene, acetone, 1, 4-dioxane, 1, 6-dioxane, tetrahydrofuran (THF) (THF), 2-methyltetrahydrofuran, N, dinethylformamide (DMF), dimethyl sulfoxide (DMSO) (DMSO), methylene dichloride, trichloromethane, tetracol phenixin, ethylene dichloride, normal hexane, ether, methyl alcohol, ethanol, n-propyl alcohol, Virahol, butanols, amylalcohol, one or more in hexanol etc.
In described synthetic method of the present invention, suitable selection can be carried out to described formula (II) and the mol ratio of (III) compound, such as mol ratio can be 1: 1-4, this scope includes any sub-range scope wherein, as 1: 1.4-3.6,1: 1.8-3.2 or 1: 2.2-2.8, also include any concrete point value wherein, exemplarily such as can be 1: 1,1: 1.5,1: 2,1: 2.5,1: 3,1: 3.5 or 1: 4.
Described formula (II) is preferably 1: 2-3 with the mol ratio of (III) compound, such as, be 1: 2,1: 2.5 or 1: 3.
In described synthetic method of the present invention, the consumption of described catalyzer is not particularly limited, such as the mol ratio of described formula (II) compound and copper source catalyzer can be 1: 0.02-0.2, such as, can be 1: 0.02,1: 0.05,1: 0.08,1: 0.11,1: 0.14,1: 0.17 or 1: 0.2.
In described synthetic method of the present invention, formula (III) compound can also be the form of salt, be such as the form of hydrochloride, vitriol, nitrate, phosphoric acid salt or hydrophosphate, the salt form compound obtained after namely can also using the inorganic acids such as above-mentioned formula (III) compound and hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid.。
In described synthetic method of the present invention, suitable selection can be carried out to the mol ratio of described formula (II) compound and alkali, such as mol ratio can be 1: 2-6, this scope includes any sub-range scope wherein, as 1: 2.4-5.6,1: 2.8-5.2,1: 3.2-4.8 or 1: 3.6-4.4, also include any concrete point value wherein, exemplarily such as can be 1: 2,1: 2.5,1: 3,1: 3.5,1: 4,1: 4.5,1: 5,1: 5.5 or 1: 6.
The mol ratio of described formula (II) compound and alkali is preferably 1: 3-5, such as, be 1: 3,1: 3.5,1: 4,1: 4.5 or 1: 5.
In described synthetic method of the present invention, temperature of reaction is 60-120 DEG C, such as can be 60 DEG C, 70 DEG C, 80 DEG C, 90 DEG C, 100 DEG C, 110 DEG C or 120 DEG C in non-limiting manner.
Described temperature of reaction is preferably 80-100 DEG C, such as, be 80 DEG C, 90 DEG C or 100 DEG C.
In described synthetic method of the present invention, reaction times, there is no particular limitation, such as by liquid chromatographic detection object product or raw material residual percentage and determine the suitable reaction times, it typically is 16-30 hour, is such as 16 hours, 18 hours, 20 hours, 22 hours, 24 hours, 26 hours, 28 hours or 30 hours in non-limiting manner.
The described reaction times is preferably 20-26 hour, such as, be 20 hours, 22 hours, 24 hours or 26 hours.
In described synthetic method of the present invention, aftertreatment after reaction terminates can adopt any known conventional processing means, such as, any one process means in crystallization, recrystallization, chromatography over CC, extraction etc. or the combination of multiple process means in organic synthesis field.As the exemplary aftertreatment means of one, such as, can be: the mixture impouring organic medium obtained after reaction being terminated as in ester class, ethers or alcohol compound, such as, is poured in ethyl acetate, then uses saturated NaHCO in turn
3the aqueous solution and salt water washing, water layer as after the extractions such as ethyl acetate, benzene, chloroform or tetrahydrofuran (THF) with conventional organic medium, merges organic layer (namely merge the organic layer after washing and extract the organic layer obtained), uses anhydrous Na HSO
4or anhydrous MgSO
4drying, negative pressure evaporation is except desolventizing, and residue is purified by flash column chromatography (elutriant such as can be n-hexane/ethyl acetate), obtains target product.
In described synthetic method of the present invention, reaction of the present invention is preferably carried out under protection of inert gas, and described rare gas element such as can be nitrogen.
In described synthetic method of the present invention, formula (II) compound as raw material can use compound well known in the prior art, or as follows, is synthesized into by anthranilamide and phenyl aldehyde:
Wherein R
1-R
4, X definition as above.
Exemplify as one is exemplary, formula (II) compound can be prepared as follows: in reaction flask, add above formula 1 compound of 1 equivalent, above formula 2 compound of 1.2 equivalents, the citric acid of 1.2 equivalents and appropriate solvent as ethanol or ethers etc., reacts 12-24 hour in reflux temperature with under stirring.After reaction terminates, use anhydrous MgSO
4or anhydrous slufuric acid hydrogen sodium is dry, concentrating under reduced pressure removing ethanol, residue 300-400 order silica gel column chromatography is separated just can obtain above-mentioned target product (II).
The third aspect, the present invention relates to the purposes of quinazo quinazolinones in the fluorescence sense field of metal ion of formula (I), such as can be used for the mark of metal ion, display, detection, fluorescent quenching etc., especially relate to described compound and be used as Fe
3+the purposes of fluorescent probe.。
By quinazo quinazolinones of the present invention being immersed in metal ion solution after certain hour, suction filtration, dry rear its solid fluorescence data of measurement, find that its fluorescence intensity has the characteristic significantly changed in some wavelength region, multiple concrete fluorescence sense field can be used it for, industrial application has a good application prospect and researching value.
In sum, the present invention by use formula (II) and (III) compound as reaction substrate, by the synergy of copper source catalyzer and alkali, and one-step synthesis obtains novel quinazo quinazolinones compounds, react simple, easy and simple to handle, yield is high, it is a kind of brand-new synthetic method of quinazo quinazolinones, preparation for this compounds provides new synthetic route, novelty teabag outside the medicinal application simultaneously having found this compounds, the expansive approach for this compounds provides research and theoretical basis.
Accompanying drawing explanation
Fig. 1 is the fluorescence intensity schematic diagram relative to wavelength after described quinazo quinazolinones of the present invention and different metal ionic bond.
Embodiment
Below by specific embodiment, the present invention is described in detail; but the purposes of these exemplary embodiments and object are only used for exemplifying the present invention; not any type of any restriction is formed to real protection scope of the present invention, more non-protection scope of the present invention is confined to this.
Embodiment 1
(A) preparation of compound (II)
In reaction flask, add 10mmol anthranilamide 1,12mmol2-bromobenzaldehyde 2,12mmol citric acid and 10ml ethanol, reflux at 80 DEG C and stir lower reaction 16 hours.After reaction terminates, use anhydrous MgSO
4drying, concentrating under reduced pressure removing ethanol, residue 400 order silica gel column chromatographies are separated to obtain target product (II), and productive rate is 81.7%.
(B) preparation of compound (I)
In the reaction vessel being equipped with agitator, thermometer, charging opening, add 50ml solvent THF, then add above formula compound (II), (III), Cu (acac)
2and Cs
2cO
3, make its mol ratio be 1: 1: 0.02: 2, its Chinese style (II) compound is 10mmol.Nitrogen replacement three times, is then continuing under the protection passing into nitrogen, reaction 16 hours under 60 DEG C and stirring.After reaction terminates, by mixture impouring ethyl acetate, use saturated NaHCO in turn
3the aqueous solution and salt water washing, after aqueous layer with ethyl acetate extraction, merge organic layer (namely merge the organic layer after washing and extract the organic layer obtained), use anhydrous Na
2sO
4drying, negative pressure evaporation is except desolventizing, and residue is purified by flash column chromatography (n-hexane/ethyl acetate), obtains the target product (I) in above formula.Productive rate is 96.8%, and purity is 98.5% (HPLC).
Fusing point: 203-205 DEG C.
Nucleus magnetic resonance:
1h NMR (500MHz, DMSO-d
6) δ 0.94 (t, J=7.4Hz, 3H), 2.26 (dq, J=14.8Hz, 7.4Hz, 1H), 2.59 (dq, J=14.8Hz, 7.4Hz, 1H), 6.18 (d, J=1.4Hz, 1H), 7.21-7.18 (m, 2H), 7.28-7.27 (m, 1H), 7.40-7.37 (m, 1H), 7.48-7.44 (m, 1H), 7.66-7.60 (m, 2H), 7.96-7.94 (m, 1H), 8.72 (s, 1H);
13C NMR(125MHz，DMSO-d
6)δ10.3，26.8，64.1，118.7，124.3，124.7，125.1，126.7，126.8，127.5，127.6，130.0，132.3，140.7，141.3，155.7，162.2。
Embodiment 2
(A) preparation of compound (II)
In reaction flask, add 10mmol2-amino-5-methyl benzamide 1,12mmol2-bromobenzaldehyde 2,12mmol citric acid and 10ml ethanol, reflux at 80 DEG C and stir lower reaction 16 hours.After reaction terminates, use anhydrous MgSO
4drying, concentrating under reduced pressure removing ethanol, residue 350 order silica gel column chromatographies are separated to obtain target product (II), and productive rate is 86.3%.
(B) preparation of compound (I)
In the reaction vessel being equipped with agitator, thermometer, charging opening, add 50ml solvent toluene, then add above formula compound (II), (III), Cu (acac)
2and Cs
2cO
3, make its mol ratio be 1: 2: 0.05: 3, its Chinese style (II) compound is 10mmol.Nitrogen replacement three times, is then continuing under the protection passing into nitrogen, reaction 20 hours under 80 DEG C and stirring.After reaction terminates, by mixture impouring ethyl acetate, use saturated NaHCO in turn
3the aqueous solution and salt water washing, after aqueous layer with ethyl acetate extraction, merge organic layer (namely merge the organic layer after washing and extract the organic layer obtained), use anhydrous MgSO
4drying, negative pressure evaporation is except desolventizing, and residue is purified by flash column chromatography (n-hexane/ethyl acetate), obtains the target product (I) in above formula.Productive rate is 97.2%, and purity is 99.1% (HPLC).
Fusing point: 278-280 DEG C;
Nucleus magnetic resonance:
1h NMR (500MHz, DMSO-d
6) δ 2.10 (s, 3H), 2.40 (s, 3H), 6.17 (s, 1H), 7.15-7.19 (m, 2H), 7.27-7.28 (m, 1H), 7.38-7.51 (m, 3H), 7.75 (s, 1H), 8.66 (s, 1H);
13C NMR(125MHz，DMSO-d
6)δ20.5，22.3，63.9，118.6，123.9，124.4，124.9，126.2，127.5，127.7，129.9，132.8，136.1，138.9，140.7，152.4，162.2。
Embodiment 3
(A) preparation of compound (II)
In reaction flask, add 10mmol2-amino-5-chlorobenzamide 1,12mmol2-bromobenzaldehyde 2,12mmol citric acid and 10ml ethanol, reflux at 80 DEG C and stir lower reaction 16 hours.After reaction terminates, use anhydrous MgSO
4drying, concentrating under reduced pressure removing ethanol, residue 400 order silica gel column chromatographies are separated to obtain target product (II), and productive rate is 82.5%.
(B) preparation of compound (I)
In the reaction vessel being equipped with agitator, thermometer, charging opening, add 50ml methylene chloride, then add above formula compound (II), (III), Cu (acac)
2and Cs
2cO
3, make its mol ratio be 1: 3: 0.08: 4, its Chinese style (II) compound is 10mmol.Nitrogen replacement three times, is then continuing under the protection passing into nitrogen, reaction 24 hours under 90 DEG C and stirring.After reaction terminates, by mixture impouring ethyl acetate, use saturated NaHCO in turn
3the aqueous solution and salt water washing, after aqueous layer with ethyl acetate extraction, merge organic layer (namely merge the organic layer after washing and extract the organic layer obtained), use anhydrous MgSO
4drying, negative pressure evaporation is except desolventizing, and residue is purified by flash column chromatography (n-hexane/ethyl acetate), obtains the target product (I) in above formula.Productive rate is 98.5%, and purity is 99.2% (HPLC).
Fusing point: 106-108 DEG C.
Nucleus magnetic resonance:
1h NMR (500MHz, DMSO-d
6) δ 2.12 (s, 3H), 6.23 (d, J=1.4Hz, 1H), 7.20-7.16 (m, 1H), 7.23-7.21 (m, 1H), 7.28-7.27 (m, 1H), 7.41-7.37 (m, 1H), 7.72-7.68 (m, 2H), 7.88 (d, J=1.3Hz, 1H), 8.89 (s, 1H);
13C NMR(125MHz，DMSO-d
6)δ22.2，63.8，118.4，124.1，125.2，126.7，126.9，127.5，128.0，130.0，130.9，132.0，140.2，140.6，151.9，161.0。
Embodiment 4
(A) preparation of compound (II)
In reaction flask, add 10mmol2-amino-5-brombenzamide 1,12mmol2-benzaldehyde iodine 2,12mmol citric acid and 10ml ethanol, reflux at 80 DEG C and stir lower reaction 16 hours.After reaction terminates, use anhydrous MgSO
4drying, concentrating under reduced pressure removing ethanol, residue 400 order silica gel column chromatographies are separated to obtain target product (II), and productive rate is 83.7%.
(B) preparation of compound (I)
In the reaction vessel being equipped with agitator, thermometer, charging opening, add 50ml solvent hexane, then add above formula compound (II), (III), Cu (acac)
2and Cs
2cO
3, make its mol ratio be 1: 4: 0.12: 5, its Chinese style (II) compound is 10mmol.Nitrogen replacement three times, is then continuing under the protection passing into nitrogen, reaction 27 hours under 110 DEG C and stirring.After reaction terminates, by mixture impouring ethyl acetate, use saturated NaHCO in turn
3the aqueous solution and salt water washing, after aqueous layer with ethyl acetate extraction, merge organic layer (namely merge the organic layer after washing and extract the organic layer obtained), use anhydrous Na
2sO
4drying, negative pressure evaporation is except desolventizing, and residue is purified by flash column chromatography (n-hexane/ethyl acetate), obtains the target product (I) in above formula.Productive rate is 97.3%, and purity is 98.7% (HPLC).
Fusing point: 235-236 DEG C.
Nucleus magnetic resonance:
1h NMR (500MHz, DMSO-d
6) δ 2.12 (s, 3H), 6.23 (d, J=1.3Hz, 1H), 7.18-7.16 (m, 1H), 7.23-7.19 (m, 1H), 7.29-7.27 (m, 1H), 7.40-7.37 (m, 1H), 7.63-7.62 (m, 1H), 7.84-7.82 (m, 1H), 8.01 (d, J=2.4Hz, 1H), 8.89 (s, 1H);
13C NMR(125MHz，DMSO-d
6)δ22.3，63.8，118.4，119.0，124.1，125.2，127.0，127.5，128.3，129.9，130.0，134.9，140.5，141.6，151.8，160.9。
Embodiment 5
(A) preparation of compound (II)
In reaction flask, add 10mmol anthranilamide 1, the bromo-5-fluorobenzaldehyde 2 of 12mmol2-, 12mmol citric acid and 10ml ethanol, reflux at 80 DEG C and stir lower reaction 20 hours.After reaction terminates, use anhydrous MgSO
4drying, concentrating under reduced pressure removing ethanol, residue 350 order silica gel column chromatographies are separated to obtain target product (II), and productive rate is 84.8%.
(B) preparation of compound (I)
In the reaction vessel being equipped with agitator, thermometer, charging opening, add 50ml solvent methanol, then add above formula compound (II), (III), Cu (acac)
2and Cs
2cO
3, make its mol ratio be 1: 1.5: 0.16: 6, its Chinese style (II) compound is 10mmol.Nitrogen replacement three times, is then continuing under the protection passing into nitrogen, reaction 30 hours under 120 DEG C and stirring.After reaction terminates, by mixture impouring ethyl acetate, use saturated NaHCO in turn
3the aqueous solution and salt water washing, after aqueous layer with ethyl acetate extraction, merge organic layer (namely merge the organic layer after washing and extract the organic layer obtained), use anhydrous Na
2sO
4drying, negative pressure evaporation is except desolventizing, and residue is purified by flash column chromatography (n-hexane/ethyl acetate), obtains the target product (I) in above formula.Productive rate is 96.9%, and purity is 98.6% (HPLC).
Fusing point: 217-218 DEG C.
Nucleus magnetic resonance:
1h NMR (500MHz, DMSO-d
6) δ 2.10 (s, 3H), 6.22 (s, 1H), 7.17-7.15 (m, 1H), 7.25-7.19 (m, 2H), 7.48-7.45 (m, 1H), 7.67-7.62 (m, 2H), (7.95 d, J=7.5Hz, 1H), 8.79 (s, 1H);
13C NMR(125MHz，DMSO-d
6)δ22.3，63.6，113.9，114.1，116.8，117.0，119.9，124.7，126.4，126.7，127.6，132.4，141.2，151.8，159.0，162.1。
Embodiment 6
(A) preparation of compound (II)
In reaction flask, add 10mmol anthranilamide 1, the bromo-5-methoxybenzaldehyde 2 of 12mmol2-, 12mmol citric acid and 10ml ethanol, reflux at 80 DEG C and stir lower reaction 16 hours.After reaction terminates, use anhydrous MgSO
4drying, concentrating under reduced pressure removing ethanol, residue 300 order silica gel column chromatographies are separated to obtain target product (II), and productive rate is 85.1%.
(B) preparation of compound (I)
In the reaction vessel being equipped with agitator, thermometer, charging opening, add 50ml solvent 1,6-dioxane, then add above formula compound (II), (III), Cu (acac)
2and Cs
2cO
3, make its mol ratio be 1: 2.5: 0.2: 3, its Chinese style (II) compound is 10mmol.Nitrogen replacement three times, is then continuing under the protection passing into nitrogen, reaction 18 hours under 70 DEG C and stirring.After reaction terminates, by mixture impouring ethyl acetate, use saturated NaHCO in turn
3the aqueous solution and salt water washing, after aqueous layer with ethyl acetate extraction, merge organic layer (namely merge the organic layer after washing and extract the organic layer obtained), use anhydrous MgSO
4drying, negative pressure evaporation is except desolventizing, and residue is purified by flash column chromatography (n-hexane/ethyl acetate), obtains the target product (I) in above formula.Productive rate is 98.1%, and purity is 98.9% (HPLC).
Fusing point: 264-266 DEG C;
Nucleus magnetic resonance
1h NMR (500MHz, DMSO-d
6) δ 2.08 (s, 3H), 3.76 (s, 3H), 6.15 (s, 1H), 6.88-6.87 (m, 1H), 6.97-6.95 (m, 1H), 7.12-7.11 (m, 1H), 7.46-7.43 (m, 1H), 7.65-7.60 (m, 2H), 7.94 (d, J=7.5Hz, 1H), 8.69 (s, 1H);
13C NMR(125MHz，DMSO-d
6)δ22.2，55.4，64.1，112.1，115.9，119.4，124.7，125.3，126.3，126.4，127.6，132.3，134.3，141.5，150.0，156.6，162.2。
Embodiment 7
(A) preparation of compound (II)
In reaction flask, add 10mmol anthranilamide 1, the iodo-4-tolyl aldehyde 2 of 12mmol2-, 12mmol citric acid and 10ml ethanol, reflux at 80 DEG C and stir lower reaction 12 hours.After reaction terminates, use anhydrous MgSO
4drying, concentrating under reduced pressure removing ethanol, residue 400 order silica gel column chromatographies are separated to obtain target product (II), and productive rate is 84.9%.
(B) preparation of compound (I)
In the reaction vessel being equipped with agitator, thermometer, charging opening, add 50ml solvent DMF, then add above formula compound (II), (III), Cu (acac)
2and Cs
2cO
3, make its mol ratio be 1: 3.5: 0.05: 2, its Chinese style (II) compound is 10mmol.Then nitrogen replacement is continuing under the protection passing into nitrogen three times, reaction 30 hours under 80 DEG C and stirring.After reaction terminates, by mixture impouring ethyl acetate, use saturated NaHCO in turn
3the aqueous solution and salt water washing, after aqueous layer with ethyl acetate extraction, merge organic layer (namely merge the organic layer after washing and extract the organic layer obtained), use anhydrous MgSO
4drying, negative pressure evaporation is except desolventizing, and residue is purified by flash column chromatography (n-hexane/ethyl acetate), obtains the target product (I) in above formula.Productive rate is 96.8%, and purity is 99.5% (HPLC).
Fusing point: 270-272 DEG C;
Nucleus magnetic resonance:
1h NMR (500MHz, DMSO-d
6) δ 2.10 (s, 3H), 3.32 (s, 3H), 6.16 (d, J=1.3Hz, 1H), 7.02-6.99 (m, 2H), 7.16-7.15 (m, 1H), 7.46-7.43 (m, 1H), 7.65-7.60 (m, 2H), 7.95-7.93 (m, 1H), 8.64 (s, 1H);
13C NMR(125MHz，DMSO-d
6)δ22.4，30.6，63.8，114.0，115.8，124.4，125.8，126.4，127.2，125.5，127.6，132.2，139.3，140.6，141.5， 152.0，162.1。
Embodiment 8
(A) preparation of compound (II)
In reaction flask, add 10mmol anthranilamide 1,12mmol2-bromo-4,5-dimethoxy phenyl aldehyde 2,12mmol citric acid and 10ml ethanol, reflux at 80 DEG C and stir lower reaction 24 hours.After reaction terminates, use anhydrous MgSO
4drying, concentrating under reduced pressure removing ethanol, residue 350 order silica gel column chromatographies are separated to obtain target product (II), and productive rate is 85.0%.
(B) preparation of compound (I)
In the reaction vessel being equipped with agitator, thermometer, charging opening, add 50ml solvent DMSO, then add above formula compound (II), (III), Cu (acac)
2and Cs
2cO
3, make its mol ratio be 1: 1: 0.1: 5, its Chinese style (II) compound is 10mmol.Nitrogen replacement three times, is then continuing under the protection passing into nitrogen, reaction 28 hours under 90 DEG C and stirring.After reaction terminates, by mixture impouring ethyl acetate, use saturated NaHCO in turn
3the aqueous solution and salt water washing, after aqueous layer with ethyl acetate extraction, merge organic layer (namely merge the organic layer after washing and extract the organic layer obtained), use anhydrous MgSO
4drying, negative pressure evaporation is except desolventizing, and residue is purified by flash column chromatography (n-hexane/ethyl acetate), obtains the target product (I) in above formula.Productive rate is 97.5%, and purity is 99.0% (HPLC).
Fusing point: 270-272 DEG C;
Nucleus magnetic resonance:
1h NMR (500MHz, DMSO-d
6) δ 2.09 (s, 3H), 3.75 (s, 3H), 3.78 (s, 3H), 6.12 (d, J=1.2Hz, 1H), 6.77 (s, 1H), 6.88 (s, 1H), 7.46-7.42 (m, 1H), 7.64-7.61 (m, 2H), 7.95-7.93 (m, 1H), 8.62 (s, 1H);
13C NMR(125MHz，DMSO-d
6)δ22.2，55.5，55.8，64.1，107.6，110.0，110.4，124.7，126.2，126.4，127.5，128.8，132.2，141.5，146.4，149.9，150.2，162.1。
Embodiment 9
In the reaction vessel being equipped with agitator, thermometer, charging opening, add 50ml solvent tetracol phenixin, then add above formula compound (II), (III), Cu (acac)
2and Cs
2cO
3, make its mol ratio be 1: 2: 0.2: 2, its Chinese style (II) compound is 10mmol.Nitrogen replacement three times, is then continuing under the protection passing into nitrogen, reaction 25 hours under 100 DEG C and stirring.After reaction terminates, by mixture impouring ethyl acetate, use saturated NaHCO in turn
3the aqueous solution and salt water washing, after aqueous layer with ethyl acetate extraction, merge organic layer (namely merge the organic layer after washing and extract the organic layer obtained), use anhydrous Na
2sO
4drying, negative pressure evaporation is except desolventizing, and residue is purified by flash column chromatography (n-hexane/ethyl acetate), obtains the target product (I) in above formula.Productive rate is 97.1%, and purity is 99.2% (HPLC).
Fusing point: 243-245 DEG C;
Nucleus magnetic resonance:
1h NMR (500MHz, DMSO-d
6) δ 0.94 (t, J=7.4Hz, 3H), 2.24 (dq, J=14.8Hz, 7.4Hz, 1H), 2.40 (s, 3H), 2.56 (dq, J=14.8Hz, 7.4Hz, 1H), 6.13 (d, J=1.5Hz, 1H), 7.21-7.18 (m, 2H), 7.28-7.26 (m, 1H), 7.40-7.36 (m, 1H), 7.45-7.43 (m, 1H), 7.49-7.48 (m, 1H), 7.76-7.75 (m, 1H), 8.65 (s, 1H);
13C NMR(125MHz，DMSO-d
6)δ10.3，20.5，26.7，64.1，118.7，124.2，124.4，125.0，126.6，127.4，127.7，129.8，132.8，136.2，138.8，140.8，155.9，162.2。
Embodiment 10
In the reaction vessel being equipped with agitator, thermometer, charging opening, add 50ml solvent, n-butanol, then add above formula compound (II), (III), Cu (acac)
2and Cs
2cO
3, make its mol ratio be 1: 1.2: 0.05: 2.5, its Chinese style (II) compound is 10mmol.Nitrogen replacement three times, is then continuing under the protection passing into nitrogen, reaction 20 hours under 90 DEG C and stirring.After reaction terminates, by mixture impouring ethyl acetate, use saturated NaHCO in turn
3the aqueous solution and salt water washing, after aqueous layer with ethyl acetate extraction, merge organic layer (namely merge the organic layer after washing and extract the organic layer obtained), use anhydrous MgSO
4drying, negative pressure evaporation is except desolventizing, and residue is purified by flash column chromatography (n-hexane/ethyl acetate), obtains the target product (I) in above formula.Productive rate is 96.8%, and purity is 98.4% (HPLC).
Fusing point: 175-176 DEG C;
Nucleus magnetic resonance:
1h NMR (500MHz, DMSO-d
6) δ 0.92 (t, J=7.4Hz, 3H), 2.22 (dq, J=14.8Hz, 7.4Hz, 1H), 2.57 (dq, J=14.8Hz, 7.4Hz, 1H), 3.76 (s, 3H), 6.12 (d, J=1.4Hz, 1H), 6.88-6.87 (m, 1H), 6.98-6.95 (m, 1H), 7.15-7.14 (m, 1H), 7.47-7.43 (m, 1H), 7.65-7.59 (m, 2H), 7.95-7.94 (m, 1H), 8.67 (s, 1H);
13C NMR(125MHz，DMSO-d
6)δ10.3，26.7，55.4，64.3，112.7，115.8，119.5，124.7，125.5，126.5，126.7，127.5，132.2，134.3，141.4，153.5，156.6，162.2。
Embodiment 11
In the reaction vessel being equipped with agitator, thermometer, charging opening, add 50ml solvent ether, then add above formula compound (II), (III), Cu (acac)
2and Cs
2cO
3, make its mol ratio be 1: 2: 0.15: 4.5, its Chinese style (II) compound is 10mmol.Nitrogen replacement three times, is then continuing under the protection passing into nitrogen, reaction 28 hours under 80 DEG C and stirring.After reaction terminates, by mixture impouring ethyl acetate, use saturated NaHCO in turn
3the aqueous solution and salt water washing, after aqueous layer with ethyl acetate extraction, merge organic layer (namely merge the organic layer after washing and extract the organic layer obtained), use anhydrous MgSO
4drying, negative pressure evaporation is except desolventizing, and residue is purified by flash column chromatography (n-hexane/ethyl acetate), obtains the target product (I) in above formula.Productive rate is 96.9%, and purity is 98.9% (HPLC).
Fusing point: 215-217 DEG C;
Nucleus magnetic resonance:
1h NMR (500MHz, DMSO-d
6) δ 0.71-0.65 (m, 1H), 0.98-0.91 (m, 2H) 1.22-1.17 (m, 1H), 1.59-1.54 (m, 1H), 6.24 (d, J=1.5Hz, 1H), 7.09-7.07 (m, 1H), 7.17-7.14 (m, 1H), 7.27-7.26 (m, 1H), 7.36-7.33 (m, 1H), 7.48-7.45 (m, 1H), 7.67-7.62 (m, 2H), 7.98-7.96 (m, 1H), 8.78 (s, 1H);
13C NMR(125MHz，DMSO-d
6)δ7.3，10.6，12.9，64.3，118.3，124.1，124.7，124.8，126.5，126.7，127.5，127.8，129.9，132.1，140.7，141.2，155.3，162.3。
Embodiment 12
In the reaction vessel being equipped with agitator, thermometer, charging opening, add 50ml solvent acetone, then add above formula compound (II), (III), Cu (acac)
2and Cs
2cO
3, make its mol ratio be 1: 1.2: 0.2: 2, its Chinese style (II) compound is 10mmol.Nitrogen replacement three times, is then continuing under the protection passing into nitrogen, reaction 17 hours under 70 DEG C and stirring.After reaction terminates, by mixture impouring ethyl acetate, use saturated NaHCO in turn
3the aqueous solution and salt water washing, after aqueous layer with ethyl acetate extraction, merge organic layer (namely merge the organic layer after washing and extract the organic layer obtained), use anhydrous MgSO
4drying, negative pressure evaporation is except desolventizing, and residue is purified by flash column chromatography (n-hexane/ethyl acetate), obtains the target product (I) in above formula.Productive rate is 96.3%, and purity is 99.4% (HPLC).
Fusing point: 214-216 DEG C;
Nucleus magnetic resonance:
1h NMR (500MHz, DMSO-d
6) δ 0.67-0.61 (m, 1H), 0.95-0.85 (m, 2H) 1.16-1.11 (m, 1H), 1.56-1.51 (m, 1H), 3.75 (s, 3H), 6.18 (d, J=1.5Hz, 1H), 6.87-6.86 (m, 1H), 6.94-6.92 (m, 1H), 7.05-7.03 (m, 1H), 7.47-7.43 (m, 1H), 7.67-7.62 (m, 2H), 7.98-7.96 (m, 1H), 8.71 (s, 1H);
13C NMR(125MHz，DMSO-d
6)δ7.0，10.3，12.9，55.3，64.5，112.09，115.8，119.0，124.8，125.3，126.3，126.5，127.7，132.1，134.3，141.3，153.1，156.3，162.4。
Embodiment 13
Be equipped with in the reaction vessel of agitator, thermometer, charging opening, add 50ml solvent chlorobenzene, then add above formula compound (II), (III), Cu (acac)
2and Cs
2cO
3, make its mol ratio be 1: 3.8: 0.04: 3.7, its Chinese style (II) compound is 10mmol.Nitrogen replacement three times, is then continuing under the protection passing into nitrogen, reaction 30 hours under 60 DEG C and stirring.After reaction terminates, by mixture impouring ethyl acetate, use saturated NaHCO in turn
3the aqueous solution and salt water washing, after aqueous layer with ethyl acetate extraction, merge organic layer (namely merge the organic layer after washing and extract the organic layer obtained), use anhydrous MgSO
4drying, negative pressure evaporation is except desolventizing, and residue is purified by flash column chromatography (n-hexane/ethyl acetate), obtains the target product (I) in above formula.Productive rate is 94.1%, and purity is 98.5% (HPLC).
Fusing point: 232-233 DEG C;
Nucleus magnetic resonance:
1h NMR (500MHz, DMSO-d
6) δ 0.73 (d, J=6.8Hz, 3H), 1.24 (d, J=6.6Hz, 3H), 3.01-2.93 (m, 1H), 6.17 (d, J=1.6Hz, 1H), 7.20-7.18 (m, 2H), 7.28-7.26 (m, 1H), 7.40-7.37 (m, 1H), 7.49-7.46 (m, 1H), 7.56-7.55 (m, 1H), 7.67-7.63 (m, 1H), 7.96-7.95 (m, 1H), 8.77 (s, 1H);
13C NMR(125MHz，DMSO-d
6)δ19.8，20.2，29.2，64.2，118.4，124.3，124.6，125.1，126.7，127.2，127.5，127.6，129.9，132.2，140.7，141.2，159.1，162.3。
Can being found out by above-described embodiment 1-13, when adopting described method of the present invention, quinazo quinazolinones can be obtained with high yield, high purity.
Embodiment 14-26
Remove Cu (acac) wherein
2replace with outside following copper compound, implement embodiment 14-26 respectively in the mode identical with embodiment 1-13, the yield of its copper source catalyzer, embodiment corresponding relation and corresponding product is as shown in the table.
As seen from the above table, when using other copper source catalyzer, equally can obtain corresponding productive rate, but product yield is wanted significantly lower than use Cu (acac)
2for yield during catalyzer.
Embodiment 27-39
Replace with except following organic bases or mineral alkali except by cesium carbonate wherein, implement embodiment 27-39 respectively respectively in the mode identical with embodiment 1-12, the yield of alkali used, embodiment corresponding relation and corresponding product is as shown in the table.
*: DABCO is Isosorbide-5-Nitrae-diazabicylo [2.2.2] octane
NR: unreacted.
As seen from the above table, out of a clear sky, when using other alkali except cesium carbonate to comprise organic bases, the productive rate of product significantly reduces, and does not even react completely.Can find out, even if use the cesium sulfate being all cesium salt, reaction also almost can not be carried out [seeing embodiment 36] simultaneously.This demonstrate that cesium carbonate has specific specificity to this reaction.
Fluorometric investigation effect
The quinazo quinazolinones (being labeled as 13I) of the embodiment of the present invention 13 gained is immersed the Ni (NO that volumetric molar concentration is 0.1mol/L respectively
3)
2, Co (NO
3)
2with Fe (NO
3)
3in the aqueous solution, soak after 20 minutes, suction filtration, and in the baking oven of 80 DEG C dry 1 hour, together with untreated embodiment 13 gained quinazo quinazolinones called after 13I, 13I+Ni respectively
2+, 13I+Co
2+and 13I+Fe
3+.
The solid fluorescence adopting Shimadzu RF-5301PC spectrophotofluorometer to measure above-mentioned four samples different long wavelength, the results are shown in accompanying drawing 1.
Can clearly be found out by Fig. 1, in 400-500nm wavelength region, the fluorescence intensity of quinazo quinazolinones of the present invention and metal ion has significant change, especially near 425nm, its fluorescence intensity and 13I fluorescence intensity change maximum, especially for 13I+Fe
3+, its fluorescence intensity is only about 50% of 13I, so means that it can be used in the embody rule such as fluorescent quenching, Fe ion detection, due to itself and Fe
3+create excellent fluorescent quenching performance, applicable work such as Fe
3+the embody rule such as fluorescent probe.Therefore, based on so strong fluorescence intensity difference, quinazo quinazolinones of the present invention can be used for multiple concrete fluorescence sense field, as metal ion identification, display, detection, fluorescent quenching etc., especially be used as Fe
3+fluorescent probe, industrial application has a good application prospect and researching value.
When using other embodiment outside embodiment 13, i.e. the quinazo quinazolinones of embodiment 1-12 gained and Ni
2+, Co
2+and Fe
3+when measuring equally, there is highly similar fluorescence to change characteristic with accompanying drawing 1, mean that these compounds also can be used for fluorescence sense field etc. equally.
In sum, can clearly be found out by above-mentioned all embodiments, when applying the method according to the invention, not only can realize the reaction to dihydroquinazoline ketone and amidine compound smoothly, and object product can be obtained with high yield and high purity, a kind of brand-new synthetic method having very much prospects for commercial application, for the efficient quick synthesis of quinazo quianzolinones provides brand-new synthetic route.In addition, also found the novelty teabag for fluorescence sense field of quinazo quianzolinones of the present invention, the expansion for its Application Areas provides theoretical basis and exploratory study.
Should be appreciated that the purposes of these embodiments is only not intended to for illustration of the present invention limit the scope of the invention.In addition; also should understand; after having read technology contents of the present invention, those skilled in the art can make various change, amendment and/or modification to the present invention, and these all equivalent form of values fall within the protection domain that the application's appended claims limits equally.
Claims (9)
1. a quinazo quinazolinones, its structural formula is as shown in the formula shown in (I):
Wherein:
R
1-R
4identical or different separately, and independently selected from H, C
1-C
6alkyl, halogen, C
1-C
6alkoxyl group;
R is selected from C
1-C
6alkyl, C
1-C
6alkoxyl group, C
3-C
6cycloalkyl;
Condition is when R is methyl, R
1-R
4be asynchronously H.
2. quinazo quinazolinones as claimed in claim 1, is characterized in that: R is C
2-C
6alkyl or C
3-C
6cycloalkyl.
3. quinazo quinazolinones as claimed in claim 2, is characterized in that: R is ethyl or cyclopropyl.
4. the quinazo quinazolinones as described in any one of claim 1-3, is characterized in that: R
4for H.
5. the synthetic method of quinazo quinazolinones as claimed in claim 1, it is characterized in that: described method makes formula (II) and (III) react and obtain formula (I) compound under being included in copper source catalyzer and alkali existence in organic solvent.
Wherein, R
1-R
4, R definition as described in the appended claim 1;
X is halogen;
Described copper source catalyzer is CuI, CuBr, CuCl, CuCl
2, CuBr
2, CuI
2in any one or multiple; Or be venus crystals, Cu (acac)
2, Cu (PPh
3)
2nO
3, ethyl acetoacetic acid copper (II), in hexafluoroacetylacetone copper any one or multiple;
Described alkali be in salt of wormwood, potassiumphosphate, Quilonum Retard, lithium hydroxide, cesium carbonate any one or multiple.
6. synthetic method as claimed in claim 5, is characterized in that: described formula (II) is 1: 1-4 with the mol ratio of (III) compound; The mol ratio of described formula (II) compound and copper source catalyzer is 1: 0.02-0.2; The mol ratio of described formula (II) compound and alkali is 1: 2-6.
7. the synthetic method as described in claim 5 or 6, is characterized in that: described copper source catalyzer is Cu (acac)
2, described alkali is cesium carbonate.
8. the synthetic method as described in claim 5 or 6, is characterized in that: temperature of reaction is 60-120 DEG C, and the reaction times is 16-30 hour.
9. the quinazo quinazolinones as described in any one of claim 1-4 is used for the purposes in fluorescence sense field.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310224222.7A CN103275085B (en) | 2013-05-30 | 2013-05-30 | Quinazoline and quinazolinone compound, its synthesis method and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310224222.7A CN103275085B (en) | 2013-05-30 | 2013-05-30 | Quinazoline and quinazolinone compound, its synthesis method and application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103275085A CN103275085A (en) | 2013-09-04 |
| CN103275085B true CN103275085B (en) | 2015-04-08 |
Family
ID=49057729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310224222.7A Expired - Fee Related CN103275085B (en) | 2013-05-30 | 2013-05-30 | Quinazoline and quinazolinone compound, its synthesis method and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103275085B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103664963B (en) * | 2013-12-23 | 2015-07-01 | 温州大学 | Method for synthesizing quinazolino indazole derivatives |
| CN105017262B (en) * | 2015-07-07 | 2017-05-03 | 广东也乐新材料制造有限公司 | Synthetic method of aldehyde multi-substituted heterocyclic aromatic hydrocarbon compound |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62192369A (en) * | 1986-02-19 | 1987-08-22 | Nippon Keikou Kagaku Kk | Fluorescent quinazolone derivative composition and production thereof |
| CN1252800A (en) * | 1997-04-25 | 2000-05-10 | 詹森药业有限公司 | Farnesyltransferase inhibiting quinazolinones |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100933498B1 (en) * | 2008-12-12 | 2009-12-23 | 신상규 | Purification method of quinazolinone compound |
| US8697714B2 (en) * | 2010-07-28 | 2014-04-15 | Nanyang Technological University | Quinazolinone based fluorogenic probes |
-
2013
- 2013-05-30 CN CN201310224222.7A patent/CN103275085B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62192369A (en) * | 1986-02-19 | 1987-08-22 | Nippon Keikou Kagaku Kk | Fluorescent quinazolone derivative composition and production thereof |
| CN1252800A (en) * | 1997-04-25 | 2000-05-10 | 詹森药业有限公司 | Farnesyltransferase inhibiting quinazolinones |
Non-Patent Citations (2)
| Title |
|---|
| Cyclisation of 2-(2-aminophenyl)quinazolin-4(3H)-one reexamined:formation of isomeric angular fused quinazolinoquinazolinones and their spectroscopic identification;Somepalli V.等;《Tetrahedron Letters》;20121231;第53卷;第2643-2646页 * |
| Synthesis of isomeric angularly fused dihydroquinazolinoquinazolinones and an unusual oxidative rearrangement;Somepalli Venkateswarlu等;《Tetrahedron Letters》;20121101;第54卷;第128-131页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103275085A (en) | 2013-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Synthesis of [11C] Iressa as a new potential PET cancer imaging agent for epidermal growth factor receptor tyrosine kinase | |
| Li et al. | One-pot synthesis of Biginelli and Hantzsch products catalyzed by non-toxic ionic liquid (BMImSac) and structural determination of two products | |
| Andleeb et al. | A one-pot multicomponent facile synthesis of dihydropyrimidin-2 (1H)-thione derivatives using triphenylgermane as a catalyst and its binding pattern validation | |
| WO2017016921A1 (en) | New crystalline forms of (6s)-10-methoxy-6-isopropyl-9-(3-methoxypropoxy)-2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid | |
| Wang et al. | Synthesis and biological evaluation of new 4β-anilino-4′-O-demethyl-4-desoxypodophyllotoxin derivatives as potential antitumor agents | |
| CN112552290B (en) | Amido bond-containing phenylfuran-2-tetrahydroisoquinoline compound and preparation method and application thereof | |
| CN105017259A (en) | Trifluoromethyl containing quinazoline derivative and preparation method and application thereof | |
| Qi et al. | Synthesis, crystal structures, fluorescence and xanthine oxidase inhibitory activity of pyrazole-based 1, 3, 4-oxadiazole derivatives | |
| CN103275085B (en) | Quinazoline and quinazolinone compound, its synthesis method and application | |
| Lu et al. | Discovery of biphenyl-based VEGFR-2 inhibitors. Part 3: design, synthesis and 3D-QSAR studies | |
| CN103601645B (en) | The preparation method of 1-(phenethyl amino) propane-2-alcohol compound or its salt | |
| Cherukumalli et al. | Design and synthesis of novel urea derivatives of pyrimidine-pyrazoles as anticancer agents | |
| Patil et al. | One step synthesis of 6-amino-5-cyano-4-phenyl-2-mercapto pyrimidine using phosphorus pentoxide | |
| CN103275017B (en) | 2-substituted quinazolinone compound, its synthesis method and application | |
| CN104529895A (en) | Synthetic method of nitrogen-containing heterocyclic compound | |
| CN111454254B (en) | Preparation and application of benzimidazole derivative with fluorine-containing substituent | |
| Gao et al. | Design, synthesis and biological evaluation of benzyloxyphenyl-methylaminophenol derivatives as STAT3 signaling pathway inhibitors | |
| CN103275086B (en) | 6-substituted quinazoline and quinazolinone compound, its synthesis method and application | |
| US8394954B2 (en) | Benzophenone hybrids as anticancer agents and processes for the preparation thereof | |
| CN106045980A (en) | Quinazoline derivative and preparation method thereof | |
| Manchukonda et al. | Synthesis and click reaction of tubulin polymerization inhibitor 9-azido-α-noscapine | |
| Shaikh et al. | Boric acid catalyzed one-pot synthesis of [1, 2, 4] triazolo quinazolinone Derivatives | |
| Parveen et al. | [Et 3 NH][HSO 4]-mediated functionalization of hippuric acid: an unprecedented approach to 4-arylidene-2-phenyl-5 (4 H)-oxazolones | |
| Bayazeed et al. | Synthesis of New Thiazole-Pyridine Hybrids and Their Anticancer Activity | |
| Šimůnek et al. | Synthesis, NMR and X-ray characterisation of 6-substituted 4-amino-5-aryldiazenyl-1-arylpyridazinium salts |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150408 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |